<!DOCTYPE pdf2xml SYSTEM "pdf2xml.dtd">
<pdf2xml producer="poppler" version="23.04.0">
<page number="1" position="absolute" top="0" left="0" height="792" width="612">
	<fontspec id="font0" size="8" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font1" size="8" family="AkzidenzGroteskBE-Md,Bold" color="#000000"/>
	<fontspec id="font2" size="8" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font3" size="7" family="AkzidenzGroteskBE-It,Italic" color="#000000"/>
	<fontspec id="font4" size="9" family="AkzidenzGroteskBE" color="#000000"/>
	<fontspec id="font5" size="9" family="AkzidenzGroteskBE,Bold" color="#000000"/>
	<fontspec id="font6" size="11" family="AkzidenzGroteskBE,Bold" color="#000000"/>
<text top="42" left="315" width="241" height="7" font="font0" id="p1_t1" reading_order_no="0" segment_no="0" tag_type="text">Available online http://breast-cancer-research.com/content/8/5/R53<b>Available online</b></text>
<text top="758" left="516" width="40" height="7" font="font2" id="p1_t2" reading_order_no="102" segment_no="14" tag_type="text">Page 3 of 9</text>
<text top="769" left="436" width="120" height="6" font="font3" id="p1_t3" reading_order_no="103" segment_no="15" tag_type="text">(page number not for citation purposes)</text>
<text top="85" left="57" width="240" height="9" font="font4" id="p1_t4" reading_order_no="1" segment_no="1" tag_type="text">The American College of Radiology recently introduced a clas-<i>(page number not for citation purposes)</i></text>
<text top="97" left="57" width="240" height="9" font="font4" id="p1_t5" reading_order_no="2" segment_no="1" tag_type="text">sification for lesions detected by MRM (adapted from the</text>
<text top="109" left="57" width="240" height="9" font="font4" id="p1_t6" reading_order_no="3" segment_no="1" tag_type="text">mammographic BI-RADS classification) [11] in five classes:</text>
<text top="120" left="57" width="240" height="9" font="font4" id="p1_t7" reading_order_no="4" segment_no="1" tag_type="text">BI-RADS I = negative finding, BI-RADS II = benign finding, BI-<a href="">tion) [11] in five classes:</a></text>
<text top="132" left="57" width="240" height="9" font="font4" id="p1_t8" reading_order_no="5" segment_no="1" tag_type="text">RADS III = probably benign finding, BI-RADS IV = suspicious</text>
<text top="144" left="57" width="240" height="9" font="font4" id="p1_t9" reading_order_no="6" segment_no="1" tag_type="text">finding, and BI-RADS V = a finding highly suggestive of</text>
<text top="156" left="57" width="46" height="9" font="font4" id="p1_t10" reading_order_no="7" segment_no="1" tag_type="text">malignancy.</text>
<text top="179" left="57" width="240" height="9" font="font4" id="p1_t11" reading_order_no="8" segment_no="3" tag_type="text">The Fischer score was accordingly converted into the MRM-</text>
<text top="191" left="57" width="240" height="9" font="font4" id="p1_t12" reading_order_no="9" segment_no="3" tag_type="text">BI-RADS score of the American College of Radiology, as fol-</text>
<text top="203" left="57" width="240" height="9" font="font4" id="p1_t13" reading_order_no="10" segment_no="3" tag_type="text">lows: Fischer 0, 1 = BI-RADS I; Fischer 2 = BI-RADS II;</text>
<text top="214" left="57" width="240" height="9" font="font4" id="p1_t14" reading_order_no="11" segment_no="3" tag_type="text">Fischer 3 = BI-RADS III; Fischer 4 and Fischer 5 = BI-RADS</text>
<text top="226" left="57" width="204" height="9" font="font4" id="p1_t15" reading_order_no="12" segment_no="3" tag_type="text">IV; Fischer 6, Fischer 7 and Fischer 8 = BI-RADS V.</text>
<text top="250" left="57" width="240" height="9" font="font4" id="p1_t16" reading_order_no="13" segment_no="5" tag_type="text">MRI findings were compared either with histological findings,</text>
<text top="261" left="57" width="240" height="9" font="font4" id="p1_t17" reading_order_no="14" segment_no="5" tag_type="text">if the patient underwent biopsy or surgery, or with a 36-month</text>
<text top="273" left="57" width="240" height="9" font="font4" id="p1_t18" reading_order_no="15" segment_no="5" tag_type="text">follow-up with the usual imaging modalities (ultrasound and/or</text>
<text top="285" left="57" width="240" height="9" font="font4" id="p1_t19" reading_order_no="16" segment_no="5" tag_type="text">mammography), if the patient did not undergo any biopsy or</text>
<text top="297" left="57" width="31" height="9" font="font4" id="p1_t20" reading_order_no="17" segment_no="5" tag_type="text">surgery.</text>
<text top="320" left="57" width="81" height="8" font="font5" id="p1_t21" reading_order_no="18" segment_no="7" tag_type="title">Statistical analysis</text>
<text top="332" left="57" width="240" height="9" font="font4" id="p1_t22" reading_order_no="19" segment_no="9" tag_type="text">True-positive, true-negative, false-positive and false-negative<b>Statistical analysis</b></text>
<text top="344" left="57" width="240" height="9" font="font4" id="p1_t23" reading_order_no="20" segment_no="9" tag_type="text">cases were recorded as follows. True-positive cases were</text>
<text top="355" left="57" width="241" height="9" font="font4" id="p1_t24" reading_order_no="21" segment_no="9" tag_type="text">patients with histological signs of disease within 3 months</text>
<text top="367" left="57" width="240" height="9" font="font4" id="p1_t25" reading_order_no="22" segment_no="9" tag_type="text">after the MRM indicating the lesion as suspicious for recur-</text>
<text top="379" left="57" width="240" height="9" font="font4" id="p1_t26" reading_order_no="23" segment_no="9" tag_type="text">rence. True-negative cases were patients with negative find-</text>
<text top="391" left="57" width="240" height="9" font="font4" id="p1_t27" reading_order_no="24" segment_no="9" tag_type="text">ings at MRM who had negative findings at ultrasonography</text>
<text top="402" left="57" width="240" height="9" font="font4" id="p1_t28" reading_order_no="25" segment_no="9" tag_type="text">and/or mammography during the following 36-month follow-</text>
<text top="414" left="57" width="240" height="9" font="font4" id="p1_t29" reading_order_no="26" segment_no="9" tag_type="text">up. False-positive cases were patients who underwent biopsy</text>
<text top="426" left="57" width="240" height="9" font="font4" id="p1_t30" reading_order_no="27" segment_no="9" tag_type="text">or surgery because MRM indicated an enhancing lesion as</text>
<text top="438" left="57" width="240" height="9" font="font4" id="p1_t31" reading_order_no="28" segment_no="9" tag_type="text">suspicious for malignancy but histological findings and follow-</text>
<text top="449" left="57" width="240" height="9" font="font4" id="p1_t32" reading_order_no="29" segment_no="9" tag_type="text">up examinations were negative for malignancies. False-nega-</text>
<text top="461" left="57" width="240" height="9" font="font4" id="p1_t33" reading_order_no="30" segment_no="9" tag_type="text">tive cases were patients who underwent biopsy or surgery</text>
<text top="473" left="57" width="240" height="9" font="font4" id="p1_t34" reading_order_no="31" segment_no="9" tag_type="text">within 3 months after a negative MRM, because of clinical,</text>
<text top="485" left="57" width="240" height="9" font="font4" id="p1_t35" reading_order_no="32" segment_no="9" tag_type="text">ultrasound or mammographic findings suspicious for recur-</text>
<text top="496" left="57" width="240" height="9" font="font4" id="p1_t36" reading_order_no="33" segment_no="9" tag_type="text">rence. These patients were considered false negative at MRM</text>
<text top="508" left="57" width="240" height="9" font="font4" id="p1_t37" reading_order_no="34" segment_no="9" tag_type="text">if histological examination demonstrated the presence of</text>
<text top="520" left="57" width="29" height="9" font="font4" id="p1_t38" reading_order_no="35" segment_no="9" tag_type="text">cancer.</text>
<text top="543" left="57" width="240" height="9" font="font4" id="p1_t39" reading_order_no="36" segment_no="11" tag_type="text">The sensitivity, specificity, positive predictive value and nega-</text>
<text top="555" left="57" width="240" height="9" font="font4" id="p1_t40" reading_order_no="37" segment_no="11" tag_type="text">tive predictive value and the accuracy of MRM in the detection</text>
<text top="567" left="57" width="240" height="9" font="font4" id="p1_t41" reading_order_no="38" segment_no="11" tag_type="text">of recurrent disease on the surgical scar were calculated. The</text>
<text top="579" left="57" width="240" height="9" font="font4" id="p1_t42" reading_order_no="39" segment_no="11" tag_type="text">same values, with 95% confidence intervals relating to the</text>
<text top="590" left="57" width="240" height="9" font="font4" id="p1_t43" reading_order_no="40" segment_no="11" tag_type="text">sensitivity and specificity, were calculated for the lesions</text>
<text top="602" left="57" width="240" height="9" font="font4" id="p1_t44" reading_order_no="41" segment_no="11" tag_type="text">detected in areas not related to the scar, in order to define the</text>
<text top="614" left="57" width="240" height="9" font="font4" id="p1_t45" reading_order_no="42" segment_no="11" tag_type="text">overall accuracy of MRM in the detection of new breast cancer</text>
<text top="626" left="57" width="29" height="9" font="font4" id="p1_t46" reading_order_no="43" segment_no="11" tag_type="text">lesions.</text>
<text top="649" left="57" width="39" height="10" font="font6" id="p1_t47" reading_order_no="44" segment_no="12" tag_type="title">Results</text>
<text top="661" left="57" width="240" height="9" font="font4" id="p1_t48" reading_order_no="45" segment_no="13" tag_type="text">Ninety-three patients (mean age, 53.3 years; range, 40â€“72<b>Results</b></text>
<text top="673" left="57" width="240" height="9" font="font4" id="p1_t49" reading_order_no="46" segment_no="13" tag_type="text">years) were evaluated in the present study: 40 patients had</text>
<text top="684" left="57" width="240" height="9" font="font4" id="p1_t50" reading_order_no="47" segment_no="13" tag_type="text">conservative surgery on the right breast, and 53 patients had</text>
<text top="696" left="57" width="240" height="9" font="font4" id="p1_t51" reading_order_no="48" segment_no="13" tag_type="text">conservative surgery on the left breast. Follow-up evaluation</text>
<text top="708" left="57" width="240" height="9" font="font4" id="p1_t52" reading_order_no="49" segment_no="13" tag_type="text">after surgery included mammography for all 93 patients and</text>
<text top="720" left="57" width="240" height="9" font="font4" id="p1_t53" reading_order_no="50" segment_no="13" tag_type="text">ultrasound for 74 patients. Recurrence was suspected by</text>
<text top="85" left="315" width="240" height="9" font="font4" id="p1_t54" reading_order_no="51" segment_no="2" tag_type="text">mammography in 27 patients (15 patients graded as mammo-</text>
<text top="97" left="315" width="241" height="9" font="font4" id="p1_t55" reading_order_no="52" segment_no="2" tag_type="text">graphic BI-RADS III, 12 patients graded as BI-RADS IV), by</text>
<text top="109" left="315" width="240" height="9" font="font4" id="p1_t56" reading_order_no="53" segment_no="2" tag_type="text">ultrasound in 58 patients (30 patients graded as US BI-RADS</text>
<text top="120" left="315" width="240" height="9" font="font4" id="p1_t57" reading_order_no="54" segment_no="2" tag_type="text">III, 28 patients graded as BI-RADS IV), and by both examina-</text>
<text top="132" left="315" width="240" height="9" font="font4" id="p1_t58" reading_order_no="55" segment_no="2" tag_type="text">tions in eight patients (one patient graded as both mammo-</text>
<text top="144" left="315" width="240" height="9" font="font4" id="p1_t59" reading_order_no="56" segment_no="2" tag_type="text">graphic and ultrasound BI-RADS III, two patients graded as</text>
<text top="156" left="315" width="240" height="9" font="font4" id="p1_t60" reading_order_no="57" segment_no="2" tag_type="text">ultrasound BI-RADS III and mammographic BI-RADS IV, three</text>
<text top="167" left="315" width="241" height="9" font="font4" id="p1_t61" reading_order_no="58" segment_no="2" tag_type="text">patients graded as ultrasound BI-RADS IV and mammo-</text>
<text top="179" left="315" width="240" height="9" font="font4" id="p1_t62" reading_order_no="59" segment_no="2" tag_type="text">graphic BI-RADS III, two patients graded as both ultrasound</text>
<text top="191" left="315" width="131" height="9" font="font4" id="p1_t63" reading_order_no="60" segment_no="2" tag_type="text">and mammographic BI-RADS IV).</text>
<text top="214" left="315" width="240" height="9" font="font4" id="p1_t64" reading_order_no="61" segment_no="4" tag_type="text">The mean time of follow-up after MRM, performed with mam-</text>
<text top="226" left="315" width="240" height="9" font="font4" id="p1_t65" reading_order_no="62" segment_no="4" tag_type="text">mography, ultrasonography or both examinations, was 36</text>
<text top="238" left="315" width="240" height="9" font="font4" id="p1_t66" reading_order_no="63" segment_no="4" tag_type="text">months (range, 12â€“48 months). The mean age of patients at</text>
<text top="250" left="315" width="157" height="9" font="font4" id="p1_t67" reading_order_no="64" segment_no="4" tag_type="text">the time of new diagnosis was 52 years.</text>
<text top="273" left="315" width="240" height="9" font="font4" id="p1_t68" reading_order_no="65" segment_no="6" tag_type="text">MRM findings were confirmed by histological findings in 29</text>
<text top="285" left="315" width="240" height="9" font="font4" id="p1_t69" reading_order_no="66" segment_no="6" tag_type="text">patients and by follow-up imaging modalities (ultrasound and/</text>
<text top="297" left="315" width="130" height="9" font="font4" id="p1_t70" reading_order_no="67" segment_no="6" tag_type="text">or mammography) in 64 patients.</text>
<text top="320" left="315" width="240" height="9" font="font4" id="p1_t71" reading_order_no="68" segment_no="8" tag_type="text">The 93 lesions studied by MRM on the surgical scar, evaluated</text>
<text top="332" left="315" width="240" height="9" font="font4" id="p1_t72" reading_order_no="69" segment_no="8" tag_type="text">according to the Fischer criteria, included 59 lesions graded</text>
<text top="344" left="315" width="240" height="9" font="font4" id="p1_t73" reading_order_no="70" segment_no="8" tag_type="text">as Fischer 0, two lesions graded as Fischer 1, eight lesions</text>
<text top="355" left="315" width="240" height="9" font="font4" id="p1_t74" reading_order_no="71" segment_no="8" tag_type="text">graded as Fischer 2, eight lesions graded as Fischer 3, 12</text>
<text top="367" left="315" width="240" height="9" font="font4" id="p1_t75" reading_order_no="72" segment_no="8" tag_type="text">lesions graded as Fischer 4, no lesions graded as Fischer 5,</text>
<text top="379" left="315" width="240" height="9" font="font4" id="p1_t76" reading_order_no="73" segment_no="8" tag_type="text">four lesions graded as Fischer 6, and no lesions graded as</text>
<text top="391" left="315" width="240" height="9" font="font4" id="p1_t77" reading_order_no="74" segment_no="8" tag_type="text">Fischer 7 and Fischer 8. The same lesions subsequently clas-</text>
<text top="402" left="315" width="241" height="9" font="font4" id="p1_t78" reading_order_no="75" segment_no="8" tag_type="text">sified into the magnetic resonance BI-RADS classification</text>
<text top="414" left="315" width="240" height="9" font="font4" id="p1_t79" reading_order_no="76" segment_no="8" tag_type="text">were: 61 lesions graded as BI-RADS I, eight lesions graded as</text>
<text top="426" left="315" width="240" height="9" font="font4" id="p1_t80" reading_order_no="77" segment_no="8" tag_type="text">BI-RADS II, eight lesions graded as BI-RADS III, 12 lesions</text>
<text top="438" left="315" width="240" height="9" font="font4" id="p1_t81" reading_order_no="78" segment_no="8" tag_type="text">graded as BI-RADS IV, and four lesions graded as BI-RADS V</text>
<text top="449" left="315" width="37" height="9" font="font4" id="p1_t82" reading_order_no="79" segment_no="8" tag_type="text">(Table 1).</text>
<text top="473" left="315" width="240" height="9" font="font4" id="p1_t83" reading_order_no="80" segment_no="10" tag_type="text">In the evaluation of enhancing lesions on the surgical scar,<a href="">able 1).</a></text>
<text top="485" left="315" width="241" height="9" font="font4" id="p1_t84" reading_order_no="81" segment_no="10" tag_type="text">nine lesions were true-positive cases. All of these lesions were</text>
<text top="496" left="315" width="241" height="9" font="font4" id="p1_t85" reading_order_no="82" segment_no="10" tag_type="text">confirmed positive by histological examination. In these cases,</text>
<text top="508" left="315" width="240" height="9" font="font4" id="p1_t86" reading_order_no="83" segment_no="10" tag_type="text">malignancy was suspected by ultrasound alone in five cases</text>
<text top="520" left="315" width="240" height="9" font="font4" id="p1_t87" reading_order_no="84" segment_no="10" tag_type="text">(three cases of BI-RADS III, two cases of BI-RADS IV), by</text>
<text top="532" left="315" width="240" height="9" font="font4" id="p1_t88" reading_order_no="85" segment_no="10" tag_type="text">mammography alone in two cases (both graded as mammo-</text>
<text top="543" left="315" width="240" height="9" font="font4" id="p1_t89" reading_order_no="86" segment_no="10" tag_type="text">graphic BI-RADS IV), and by both examinations in two cases</text>
<text top="555" left="315" width="240" height="9" font="font4" id="p1_t90" reading_order_no="87" segment_no="10" tag_type="text">(one case graded as mammographic BI-RADS IV and ultra-</text>
<text top="567" left="315" width="240" height="9" font="font4" id="p1_t91" reading_order_no="88" segment_no="10" tag_type="text">sound BI-RADS III, one case graded as both mammographic</text>
<text top="579" left="315" width="241" height="9" font="font4" id="p1_t92" reading_order_no="89" segment_no="10" tag_type="text">and ultrasound BI-RADS IV). Histological proof of malignancy</text>
<text top="590" left="315" width="240" height="9" font="font4" id="p1_t93" reading_order_no="90" segment_no="10" tag_type="text">was obtained with a vacuum-assisted breast biopsy in four</text>
<text top="602" left="315" width="240" height="9" font="font4" id="p1_t94" reading_order_no="91" segment_no="10" tag_type="text">patients, with a tru-cut biopsy in three cases, with fine-needle</text>
<text top="614" left="315" width="241" height="9" font="font4" id="p1_t95" reading_order_no="92" segment_no="10" tag_type="text">aspiration cytology in one case, and with fine-needle aspiration</text>
<text top="626" left="315" width="240" height="9" font="font4" id="p1_t96" reading_order_no="93" segment_no="10" tag_type="text">cytology + tru-cut in one case. Four out of nine patients under-</text>
<text top="637" left="315" width="240" height="9" font="font4" id="p1_t97" reading_order_no="94" segment_no="10" tag_type="text">went a complete mastectomy, 2/9 underwent a second con-</text>
<text top="649" left="315" width="240" height="9" font="font4" id="p1_t98" reading_order_no="95" segment_no="10" tag_type="text">servative treatment (quadrantectomy), 1/9 died without</text>
<text top="661" left="315" width="240" height="9" font="font4" id="p1_t99" reading_order_no="96" segment_no="10" tag_type="text">undergoing further surgery (histological confirmation of recur-</text>
<text top="673" left="315" width="240" height="9" font="font4" id="p1_t100" reading_order_no="97" segment_no="10" tag_type="text">rence came from biopsy), and the remaining 2/9 underwent</text>
<text top="684" left="315" width="241" height="9" font="font4" id="p1_t101" reading_order_no="98" segment_no="10" tag_type="text">surgery in other institutions â€“ we received the pathological</text>
<text top="696" left="315" width="240" height="9" font="font4" id="p1_t102" reading_order_no="99" segment_no="10" tag_type="text">report without a detailed description of the type of surgery.</text>
<text top="708" left="315" width="241" height="9" font="font4" id="p1_t103" reading_order_no="100" segment_no="10" tag_type="text">Histological types of the true-positive cases were 8/9 infiltrat-</text>
<text top="720" left="315" width="240" height="9" font="font4" id="p1_t104" reading_order_no="101" segment_no="10" tag_type="text">ing ductal carcinoma and 1/9 cribriform infiltrating carcinoma.</text>
</page>
</pdf2xml>
